ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000015077
Date of registration:	12/09/2014
Prospective Registration:	No
Primary sponsor:	Department of Anesthesiology and CCM, Asahikawa Medical University
Public title:	Pharmakocinetics of landiolol in patients with peripheral arterial disease
Scientific title:	Pharmakocinetics of landiolol in patients with peripheral arterial disease - Pharmakocinetics of landiolol in patients with peripheral arterial disease
Date of first enrolment:	2007/11/01
Target sample size:	8
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017539
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Takayuki Kunisawa
Address:	2-1-1-1, Midorigaoka-higashi, Asahikawa, Hokkaido
Telephone:	+81-166-68-2583
Email:	taka.kunisawa@nifty.ne.jp
Affiliation:	Asahikawa Medical University Anesthesiology and CCM

Name:	Takayuki Kunisawa
Address:	2-1-1-1, Midorigaoka-higashi, Asahikawa, Hokkaido Japan
Telephone:	81-166-68-2583
Email:	taka.kunisawa@nifty.ne.jp
Affiliation:	Asahikawa Medical University Anesthesiology and CCM

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: Patients with arrhythmia and patients medicated with alpha-methyldopa, clonidine or beta-blocker

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Peripheral arterial disease

Intervention(s)

Landiolol was administered at target concentrations of 0.5 and 1.0 mcg/mL for each 30 min at each target concentration.

Primary Outcome(s)

Plasma concentration of landiolol from the start of administration until 20 min after the end of administration

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Japan Society for the Promotion of Science

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.